Katarina D Kovacevic1, Florian J Mayer2, Bernd Jilma3, Nina Buchtele1, Georg Obermayer2, Christoph J Binder2, Andrew D Blann4, Erich Minar5, Martin Schillinger5, Matthias Hoke5. 1. Medical University of Vienna, Clinical Pharmacology, Vienna, Austria. 2. Medical University of Vienna, Department of Laboratory Medicine, Vienna, Austria. 3. Medical University of Vienna, Clinical Pharmacology, Vienna, Austria. Electronic address: bernd.jilma@meduniwien.ac.at. 4. University of Birmingham, Institute for Cardiovascular Sciences, Birmingham, United Kingdom. 5. Medical University of Vienna, Department for Internal Medicine II, Vienna, Austria.
Abstract
BACKGROUND AND AIMS: Von Willebrand factor (VWF) plays an important role in thrombogenesis and mediates platelet adhesion particularly under high shear stress. Such conditions are generally found in stenotic arteries and can eventually cause myocardial infarction or stroke. We aimed to study whether levels of VWF antigen (VWF:Ag) predict future major adverse cardiovascular events (MACE) in patients suffering from carotid artery stenosis. METHODS: Patients with atherosclerotic carotid artery disease defined by the presence of nonstenotic plaques or any degree of carotid stenosis were prospectively enrolled. Concentrations of VWF were measured by enzyme immunoassay. RESULTS: VWF:Ag levels were more stable after 4 freeze-thaw cycles, when compared to VWF activity, and we showed similar concentrations of VWF in citrated plasma and serum (±4%). Levels of VWF:Ag predicted future cardiovascular events in 811 patients with carotid stenosis independent of known cardiovascular risk factors. Patients with VWF:Ag concentrations in the 4th quartile had a 44% event rate after an average 3-year follow up and a hazard ratio of 2.15 (95% confidence interval 1.46-3.16; p < 0.001). CONCLUSIONS: High concentrations of VWF:Ag predict major cardiovascular events in patients with carotid stenosis, and given their high event rate may be useful for risk stratification of such patients.
BACKGROUND AND AIMS: Von Willebrand factor (VWF) plays an important role in thrombogenesis and mediates platelet adhesion particularly under high shear stress. Such conditions are generally found in stenotic arteries and can eventually cause myocardial infarction or stroke. We aimed to study whether levels of VWF antigen (VWF:Ag) predict future major adverse cardiovascular events (MACE) in patients suffering from carotid artery stenosis. METHODS:Patients with atherosclerotic carotid artery disease defined by the presence of nonstenotic plaques or any degree of carotid stenosis were prospectively enrolled. Concentrations of VWF were measured by enzyme immunoassay. RESULTS:VWF:Ag levels were more stable after 4 freeze-thaw cycles, when compared to VWF activity, and we showed similar concentrations of VWF in citrated plasma and serum (±4%). Levels of VWF:Ag predicted future cardiovascular events in 811 patients with carotid stenosis independent of known cardiovascular risk factors. Patients with VWF:Ag concentrations in the 4th quartile had a 44% event rate after an average 3-year follow up and a hazard ratio of 2.15 (95% confidence interval 1.46-3.16; p < 0.001). CONCLUSIONS: High concentrations of VWF:Ag predict major cardiovascular events in patients with carotid stenosis, and given their high event rate may be useful for risk stratification of such patients.
Authors: Katarina D Kovacevic; Nina Buchtele; Christian Schoergenhofer; Ulla Derhaschnig; Georg Gelbenegger; Christine Brostjan; Shuhao Zhu; James C Gilbert; Bernd Jilma Journal: Sci Rep Date: 2020-07-07 Impact factor: 4.379
Authors: Jay S Shavadia; Christopher B Granger; Wendimagegn Alemayehu; Cynthia M Westerhout; Thomas J Povsic; Sean Van Diepen; Christopher Defilippi; Paul W Armstrong Journal: J Am Heart Assoc Date: 2020-06-17 Impact factor: 5.501
Authors: Susan M Graham; Robin M Nance; Junmei Chen; Jennie Le; Dominic W Chung; Mark M Wurfel; David L Tirschwell; Joseph R Zunt; Christina M Marra; Emily L Ho; Andrew Huffer; Felicia C Chow; Jeffrey N Martin; Alice S Ryan; Heidi M Crane; José A López; W Conrad Liles Journal: Open Forum Infect Dis Date: 2021-10-21 Impact factor: 4.423
Authors: Ivan Melnikov; Sergey Kozlov; Olga Pogorelova; Maria Tripoten; Leyla Khamchieva; Olga Saburova; Yuliya Avtaeva; Maria Zvereva; Evgeny Matroze; Tatiana Kuznetsova; Lyudmila Prokofieva; Tatiana Balakhonova; Zufar Gabbasov Journal: Front Cardiovasc Med Date: 2022-07-22
Authors: Peter Kamstrup; Jannie Marie Bülow Sand; Charlotte Suppli Ulrik; Julie Janner; Christian Philip Rønn; Sarah Rank Rønnow; Diana Julie Leeming; Sidse Graff Jensen; Torgny Wilcke; Alexander G Mathioudakis; Marc Miravitlles; Therese Lapperre; Elisabeth Bendstrup; Ruth Frikke-Schmidt; Daniel D Murray; Theis Itenov; Apostolos Bossios; Susanne Dam Nielsen; Jørgen Vestbo; Tor Biering-Sørensen; Morten Karsdal; Jens-Ulrik Jensen; Pradeesh Sivapalan Journal: Biomedicines Date: 2022-08-19